Tag: immuno-oncology
July 29, 2015
NantKwest's Record-breaking $2.6-billion IPO Valuation
NantKwest hit the stock market on Tuesday with an initial public offering hat values the company at $2.6 billion. July 23, 2015
Roche Pushes Ahead Late-Stage Pipeline Drugs to Stay In Front of Competition
Noticing biosimilar competition on the horizon, Roche Holding (OTCMKTS:RHHBY)(VTX:ROG) is aggressively pushing ahead with its late-stage pipeline drugs. In particular,... July 10, 2015
Merck's Progress in Critical Growth Areas Increases Valuation
Forbes reports that it has upgraded Merck's (NYSE:MRK) valuation on the basis of its success in two key areas, Hepatitis... July 8, 2015